WESTBOROUGH, Mass., Feb. 4 /PRNewswire/ -- IBC announced its 8th International Intensive Symposium on Biological Assay Development & Validation to be held April 26-28, 2004 at the Sheraton San Diego Hotel & Marina in San Diego, CA. Focusing on techniques for accelerating product approval, this event has a history of tracking the newest developments, the latest thinking, and attracting the best case studies. It is considered a "must attend" for bioassay development scientists or bioanalytical scientists utilizing novel biological methods, immunoassays or other assay methods.
"Designed by practicing bioassay scientists for other practicing bioassay scientists, this event continues to be the leading resource for bioassay developers," says Laureen Little, Ph.D., Principal Consultant, Quality Services, Editor/Publisher of BioQuality, i2i Corporation, who is co-chairing this event with Sally Seaver, Ph.D., President, Seaver Associates
Some of the many highlights will include; the FDA perspectives on biological immunogenicity assays, updates on the Chapter <111> rewrite, practical hands-on data from NIBSC scientists, and validation hints from industry leaders with successful, real-world experience. An array of case studies will be presented including; immunogenicity assays to monitor patient samples, automating biological assays and qualifying your instrumentation, rapid bioassays using early signaling events, monitoring stability and releasing product with biological assays, developing potency assays for gene therapy products, validation and use of ELISpot for product development, and potency assay for vaccine release.
In addition to the high quality content, this conference offers two half day validation short courses on: Preparing your instrumentation for the Regulated Laboratory -- Practical Instrument Qualification and Documentation for Validation Series: Pre-Validation to Final Report and a full day course on Everyday Statistics for the Bioassay Scientist to take place prior to the main conference.
Conveniently Co-Located with IBC's Inaugural Early Development for Biotherapeutics, this venue lends itself to enhanced networking where the attendees will share sessions on Tuesday, April 27, 2004 designed to help attendees accelerate their assay development efforts to better support preclinical development studies, product development and product comparison in supporting process change. The shared sessions will feature 5 case studies, luncheons, and a cocktail reception.
ATTENTION CALENDAR EDITORS! For more information on attending Biological Assay Development & Validation at the Sheraton San Diego Hotel & Marina, in San Diego, CA visit http://www.lifesciencesinfo.com/3011
CONTACT: Kerry Patterson EMAIL: kpatterson@ibcusa.com
IBCCONTACT: Kerry Patterson of IBC, kpatterson@ibcusa.com
Web site: http://www.lifesciencesinfo.com/
